Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Ma

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Cancer|October 12, 2013
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alphaBrigette B Y Ma, Stephen L Chan, Wing M Ho, et al.
Journal of Gastroenterology and Hepatology|January 26, 2011
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian populationStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Cancers|March 29, 2023
Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon RadiotherapyShweta Mahajan, Hayri E Balcioglu, Astrid Oostvogels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaAnthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.
Cancer Letters|June 14, 2022
Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathwayBonan Chen, Yue Song, Yujuan Zhan, et al.
Oncogene|June 5, 2007
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomasH Jin, X Wang, J Ying, et al.
AJNR. American Journal of Neuroradiology|October 30, 2020
Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the NasopharynxQ Y H Ai, W Chen, T Y So, et al.
Clinical Chemistry|March 20, 2020
Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant ProfilesW K Jacky Lam, Lu Ji, O Y Olivia Tse, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 4, 2011
Association of molecular marker O(6)Methylguanine DNA methyltransferase and concomitant chemoradiotherapy with survival in Southern Chinese glioblastoma patientsDanny T M Chan, Michael K M Kam, Brigette B Y Ma, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Cancer|October 12, 2013
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alphaBrigette B Y Ma, Stephen L Chan, Wing M Ho, et al.
Journal of Gastroenterology and Hepatology|January 26, 2011
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian populationStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Cancers|March 29, 2023
Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon RadiotherapyShweta Mahajan, Hayri E Balcioglu, Astrid Oostvogels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaAnthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.
Cancer Letters|June 14, 2022
Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathwayBonan Chen, Yue Song, Yujuan Zhan, et al.
Oncogene|June 5, 2007
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomasH Jin, X Wang, J Ying, et al.
AJNR. American Journal of Neuroradiology|October 30, 2020
Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the NasopharynxQ Y H Ai, W Chen, T Y So, et al.
Clinical Chemistry|March 20, 2020
Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant ProfilesW K Jacky Lam, Lu Ji, O Y Olivia Tse, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 4, 2011
Association of molecular marker O(6)Methylguanine DNA methyltransferase and concomitant chemoradiotherapy with survival in Southern Chinese glioblastoma patientsDanny T M Chan, Michael K M Kam, Brigette B Y Ma, et al.
Pageof 15